Biotest AG (Biotest AG) COGS-to-Revenue : 0.58 (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Biotest AG COGS-to-Revenue?

Biotest AG's Cost of Goods Sold for the three months ended in Mar. 2024 was $135.4 Mil. Its Revenue for the three months ended in Mar. 2024 was $233.9 Mil.

Biotest AG's COGS to Revenue for the three months ended in Mar. 2024 was 0.58.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Biotest AG's Gross Margin % for the three months ended in Mar. 2024 was 42.10%.

Biotest AG COGS-to-Revenue Historical Data

The historical data trend for Biotest AG's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotest AG COGS-to-Revenue Chart

Biotest AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.69

0.73

0.84

0.76

0.59

Biotest AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.79	0.70	0.34	0.63	0.58

Biotest AG COGS-to-Revenue Calculation

Biotest AG's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	440.894	/	746.565
	=	0.59

Biotest AG's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	135.435	/	233.913
	=	0.58

Biotest AG (OTCPK:BIESF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Biotest AG's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	135.435 / 233.913
	=	42.10 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Biotest AG COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Biotest AG's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotest AG (Biotest AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotest AG (OTCPK:BIESF) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

BIO3:Germany BIO3:Austria

Address

Landsteinerstrasse 5, Dreieich, DEU, 63303

Website

https://www.biotest.com

Biotest AG is a supplier of biological medicines. The company produces its products from human blood plasma or manufactured by using biotechnology methods. It is engaged in the area of hematology, clinical immunology, and intensive care medicine. The operating business segments are Therapy, Plasma and Services, and Other segments. It generates maximum revenue from the Therapy segment. Geographically, it derives a majority of revenue from Central Europe and also has a presence in other countries.